1512 ET - Chemours, the producer of fluorine-based refrigerants, specialty plastics and titanium dioxide pigments, is entering a more favorable environment, according to Mizuho in a research report. Analysts say one major tailwind is that industry stockpiling of the banned refrigerant Freon is normalizing amid the larger shift to next-gen refrigerants, of which Chemours is one of only two producers. The analysts also say that litigation surrounding PFAS, also known as forever chemicals, seems to be moving in the right direction. They believe a potential settlement in advance of the New Jersey PFAS trial, anticipated in spring/summer, would likely help limit the scope of Chemours' potential liability. Mizuho upgrades Chemours to outperform from neutral. Chemours is up 2.6% to $14.19. (sarina.isaacs@wsj.com)
(END) Dow Jones Newswires
March 27, 2025 15:14 ET (19:14 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。